Maternal and perinatal outcomes in women with polycystic ovarian syndrome
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20240770Keywords:
PCOS, Pregnancy complications, Hypertension, Perinatal outcomeAbstract
Background: Pregnant individuals with polycystic ovarian syndrome (PCOS) seem to face a heightened susceptibility to unfavorable outcomes. This investigation aimed to evaluate the consequences of pregnancies in patients diagnosed with PCOS.
Methods: This cross-sectional study involving 115 pregnant patients with PCOS was carried out at the department of obstetrics and gynecology, Dhaka medical college and hospital, Dhaka, Bangladesh, tertiary care facility, from January 2023 to December 2023. Data on the ongoing pregnancy, PCOS, and outcomes were analyzed by SPSS version 20.
Results: Average age of participants was 25.07 years. Incidence of premature rupture of membranes (PROM) was 33.91%, low APGAR score at 5 minutes was 12.17%, gestational diabetes (GDM) occurred in 23.47% of cases, miscarriage was reported in 2.1%, preterm delivery in 13.91%, cesarean delivery in 37.39%, low birth weight babies accounted for 2.6%, macrosomia occurred in 0.7%, preterm PROM (PPROM) in 19.52%, perinatal mortality 1.73%.
Conclusions: In pregnancy with PCOS, the percentage of GDM, preterm delivery, meconium-stained liquor, small for gestational age (SGA)/intrauterine growth restriction (IUGR), macrosomia, PPROM, perinatal mortality, neonatal intensive care unit (NICU) admission, and congenital anomalies were either comparable or lower. However, a higher percentage of hypertension in pregnancy, PROM, low birth weight babies, and low APGAR score at five minutes was observed in this population.
References
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group: Long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41-7.
Galtier-Dereure F, Boegner C, Bringer J: Obesity and pregnancy complications and cost. Am J Clin Nutr. 2000;71(5):1242S-8S.
Wild RA. Long-term health consequences of PCOS. Hum Reprod Update. 2002;8(3):231-41.
Bjercke S, Dale PO, Tanbo T, Storeng R, Ertzeid G, Abyholm T. Outcome in women with polycystic ovary syndrome. Gynecol Obstet Invest. 2002;54(2):94-8.
Glueck CJ, Goldenberg N, Wang P, Loftspring M, Sherman A. Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy. Hum Reprod. 2004;19:510-21.
Eijkemans MJ, Imani B, Mulders AG, Habbema JD, Fauser BC. High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility (WHO 2). Hum Reprod. 2003;18(11):2357-62.
Palomba S, Falbo A, Russo T, Tolino A, Orio F, Zullo F. Pregnancy in women with polycystic ovary syndrome. Fertil Steril. 2010;94(5):1805-11.
Doherty DA, Newnham JP, Bower C, Kart R. Implications of polycystic ovary syndrome for pregnancy and for the health of offspring. Obstet Gynecol. 2015;125(6):1397-4.
Kollmann M, Klaritsch P, Martins WP. Maternal and neonatal outcomes in pregnant women with PCOS. Hum Reprod. 2015;30(10):2396.
Frene VD, Vansteelandt S, Sjoen GT, Gerris J, Somers S, Vercruysse L, et al. A retrospective study in overweight versus normal-weight women with polycystic ovary syndrome. Hum Reprod. 2014;29(10):1-6.
Palomba S, Dewilde MA, Falbo A, Maria PHK, Giovanni BLS, Bart CJMF. Pregnancy complications in women with polycystic ovary syndrome. Hum Reprod. 2015;21(5):575-92.
Qin JZ, Pang LH, Li MJ, Fan XJ, Huang RD, Chen HY. Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2013;11:56.
Yu HF, Chen HS, Rao DP, Gong J. Association between polycystic ovary syndrome and the risk of pregnancy complications. Medicine (Baltimore). 2016;95(51): e4863.
Roos N, Kieler H, Sahlin L, Ekman-Ordeberg G, Falconer H, Stephansson O. Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: BMJ. 2011;343:d6309.
Kjerulf LE, Sanchez-Ramos L, Dufy D. Pregnancy outcomes in women with polycystic ovary syndrome: a meta-analysis. Am J Obstet Gynecol. 2011;204(6):558.e551-6.
Amita G, Kapila R, Tania K, Veer Y. Pregnancy outcome in women with polycystic ovarian syndrome. JK Sci. 2009;11(2):82-4.
Puvithra T, Pandiyan R, Pandiyan N. Consequence of polycystic ovary syndrome or body mass index. Chettinad Health City Med J. 2017;6(1):04-8.
Nandita PP, Hrishikesh DP. Metformin throughout pregnancy in women with polycystic ovary syndrome: safety and advantages. Int J Infertil Fetal Med. 2011;2(2):61-4.
Mikova M, Hiileesma V, Halttunen M, Suhonen L, Tiitinen A. Obstetrics outcome in women with polycystic ovary syndrome. Hum Reprod. 2001;16(2):226-9.
Sir-Petermann T, Hitchsfeld C, Maliqueo M, Ethel C, Bárbara E, Raimundo G. Birth weight in offspring of mothers with polycystic ovarian syndrome. Hum Reprod. 2005;20:2122-6.
Cunningham FG, Leveno JK, Bloom SL, Dashe JS, Hoffman BL, Casey BM, et al. Williams obstetrics, 25th ed. New York: McGraw-Hill. 2018.
